SwissChems reviews
Claiming is free. Verify ownership, add company details, upload lab reports, and respond to reviews.
Trust Score pending. The factor breakdown appears once the first approved buyer review is on file.
How the Trust Score worksTiers summarize public third-party evidence and are not a certification.
Note on file: States independently tested with a purity-refund guarantee; no named lab or public batch-COA library captured.
What SwissChems says about itself.
Statements below are the company's own, taken from its website. PeptideReg has not verified them.
Time in business and corporate record.
Every item below is sourced. Where a record could not be located, that is stated rather than assumed.
Press and public record.
Coverage and official records naming this company. Allegations are reported as what the source alleges.
Regulatory record
FDA stated it reviewed the website swisschems.is in October 2024 and observed Semaglutide and Retatrutide products offered for sale, which it classified as unapproved new drugs under sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act. One of four letters issued the same day, alongside Prime Peptides, Summit Research Peptides, and Xcel Research. Open the source
No civil litigation, class action, or state enforcement action located for this company as of July 2026.
Coverage
PeptideReg analysis.
What the record shows
- A legal entity, Swisschems, is named in an official record (FDA warning letter addressee).
- An address appears in the located record: 42 Broadway FL 12, New York NY 10004 (operating address); 8 The Grn Ste 10208, Dover DE also listed (FDA warning letter and company contact page).
- The company publishes its own statements on founded, payments, shipping, and reship, set out above. They are the company's words and PeptideReg has not verified them.
- Items naming this company were located at FDA. They are set out above with their source labels.
- U.S. Food and Drug Administration published a warning letter naming this company on 10 December 2024, reference MARCS-CMS 695663. FDA stated it reviewed the website swisschems.is in October 2024 and observed Semaglutide and Retatrutide products offered for sale, which it classified as unapproved new drugs under sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act. One of four letters issued the same day, alongside Prime Peptides, Summit Research Peptides, and Xcel Research.
- No civil litigation, class action, or state enforcement action located for this company as of July 2026.
What we could not verify
- The company's testing statements. No named laboratory and no batch-level certificate of analysis was confirmed, which is why the lab tier is pending rather than assigned.
- No state business registration located for this company as of July 2026.
- No registered trademark located for this company as of July 2026.
- No individual is named in any source located for this company as of July 2026.
- No approved buyer review is on file yet, so nothing on this page reflects a customer's experience of ordering.
- Stated: Swiss branding and company name. Located record: Operating address is New York, NY per its own contact page and the FDA letter. US company despite the name.
What to check yourself before ordering
- Check whether a batch-level certificate of analysis is reachable from the specific product page you are buying, and whether the issuing laboratory is named on it.
- Read the shipping, reship, and refund terms in full before you pay. Note which payment methods are offered at checkout and what recourse each one gives you.
- Read the regulator's published letter yourself. It is linked in the public record above.
- Where the company's statements and the located record differ, the difference is set out above. Ask the company directly if it affects your decision.
Buyer reviews.
No verified customer reviews yet. Ordered from SwissChems? Yours sets the record.
Write a review.
About 90 seconds. The next buyer checks here first.
Write a review.
About 90 seconds. The next buyer checks here first.
Frequently asked.
PeptideReg does not certify or endorse companies. SwissChems currently shows a pending Trust Score with no approved reviews yet, lab tier pending, and 0 approved buyer reviews (0 verified). Review the evidence and decide.
No lab report tier assigned yet. Current note on file: states independently tested with a purity-refund guarantee; no named lab or public batch-coa library captured.
Card, Crypto, Zelle, ACH, Other, per profile data and buyer reports.
Similar companies.
Explore the registry.
Companies with a registered legal entity on file
Companies with a lab tier pending
Companies accepting the same payment methods
Browse the registry
More companies on the registry
Showing 55 of 173 companies on the registry.


